Welcome to our dedicated page for WLTH news (Ticker: WLTH), a resource for investors and traders seeking the latest updates and insights on WLTH stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect WLTH's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of WLTH's position in the market.
Wealthfront (WLTH) launched the roadshow for a proposed initial public offering on Dec. 2, 2025. The company filed a Form S-1 to offer 34,615,384 shares of common stock, including 21,468,038 shares by Wealthfront and 13,147,346 shares by existing selling stockholders.
Wealthfront expects an IPO price range of $12.00 to $14.00 per share, has applied to list on the Nasdaq Global Select Market under ticker WLTH, and granted underwriters a 30-day option for up to 5,192,308 additional shares. Goldman Sachs and J.P. Morgan are lead book-runners.
